Ten Years Later: Jesse Gelsinger’s Death and Human Subjects Protection
By Osagie K. Obasogie,
Bioethics Forum
| 10. 22. 2009
Last month marked the tenth anniversary of Jesse Gelsinger's death. While perhaps not quite a household name, Gelsinger is vividly remembered among many medical researchers. His death during a gene therapy clinical trial in September 1999 rocked the field like nothing else since the Tuskegee experiments. But sadly, the questionable research practices that led to Gelsinger's death have only become more troublesome in the past decade. Indeed, protections for clinical trial participants seem to be waning at the very moment they are needed most.
Gelsinger suffered from orinthine trascarbamlase deficiency (OTCD), a rare metabolic disorder that prevents the body from breaking down ammonia. Many children with OTCD die at a young age, but Gelsinger had a mild version and led a fairly normal life through medicine and a special diet. Since a single-gene defect is responsible for OTCD, researchers considered it a prime candidate for gene therapy, a still-experimental treatment that attempts to replace defective genes with normal ones.
Gene therapy was the embryonic stem cell research of the 1990s; its ability to cure was thought to be boundless and... see more
Related Articles
By Osagie Obasogie, The Washington Post | 06.05.2020
Photo by AJ Colores on Unsplash
Pandemics are often thought to be unforeseeable acts of God that emerge suddenly to wreak havoc on unsuspecting populations. But that’s not how public health practitioners think about them. More often than not, pandemics...
By Michael Le Page, New Scientist | 05.13.2020
Biologists have created mouse-human chimeras whose bodies were composed of up to 4 per cent human cells when the early embryos were destroyed after 17 days. The highest proportion previously achieved is around 0.1 per cent.
The reason for creating...
By Isaac Chotiner, The New Yorker | 05.07.2020
Evelynn Hammonds, who chairs Harvard’s department of the history of science, has spent her career studying the intersection of race and disease. She wrote a history of New York City’s attempt, a century ago, to control diphtheria, and is currently...
By Gregory Walton, AFP | 05.24.2020
Doha (AFP) - Privacy concerns over Qatar's coronavirus contact tracing app, a tool that is mandatory on pain of prison, have prompted a rare backlash and forced officials to offer reassurance and concessions.
Like other governments around the world, Qatar...
